- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
DJNJ3
BUE
Week ended 31 Jul 2026
Weekly Investor Report
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Latest close
2,500 ARS
52.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 47.3% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 52.4%, after a 52.4% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: price is close to its 52-week high.
Setup score
52
out of 100
Latest Close
2,500 ARS
31 Jul 2026
1W Return
52.4%
latest completed week
4W Return
52.4%
short-term follow-through
12W Return
52.4%
quarterly tape
Trend Breadth
2.1%
1 of 47 weeks active
Volume Ratio
13.0x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 0.00% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
52.4%
Latest completed week; four-week move 52.4%.
Indicator stack
5/55
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 0.00%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 47.3% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 52.4%, after a 52.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 13.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.00
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 52.4% over four weeks, 52.4% over 12 weeks, and - over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year1
Trend breadth2.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.09Latest activity-pressure read.
Pressure change77.8%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 13 relevant articles.
4 positive · 7 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown0.0%Distance below the 52-week high.
13-week volatility14.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher2 of 262 weeks finished lower.
Best week+52.4%Week of 31 Jul.
Worst week-4.8%Week of 20 Feb.
Latest week+52.4%Week of 31 Jul.
Shape of recent returns
Strong gains1
Modest gains1
Flat weeks22
Modest losses1
Sharp losses1
Recent vol14.0%13-week weekly-return volatility.
Base vol7.8%52-week weekly-return volatility.
Up/down split4/2Count of positive and negative weeks in the 52-week window.
Average skew15.1% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAR Healthcare
4-week rank1 / 20
Group average1.7%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD80.0%positive activity pressure
RS35.0%positive relative leadership
Four-week leaders
IndustryAR Drug Manufacturers - General
4-week rank1 / 13
Group average1.5%
Trend breadth69.2%
Trend69.2%active weekly trend signals
MD76.9%positive activity pressure
RS46.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape42/100
Trend, activity pressure, participation, and risk combine to a 42/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.03; 1 reversal markers Next-Week ExpectancyNegative 0.00%Next-week expectancy is negative with a 0.00% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 13 relevant articles.
Johnson & Johnson reaches $5.5 billion baby powder settlement Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 2,500 ARS | 52.4% | 1,697 ARS | 1,700 ARS | -0.09 | - | 67 | On |
| 24 Jul 2026 | 1,640 ARS | 0.0% | 1,672 ARS | 1,683 ARS | -0.15 | - | 0 | Off |
| 17 Jul 2026 | 1,640 ARS | 0.0% | 1,675 ARS | 1,684 ARS | -0.22 | - | 0 | Off |
| 10 Jul 2026 | 1,640 ARS | 0.0% | 1,679 ARS | 1,685 ARS | -0.30 | - | 0 | Off |
| 3 Jul 2026 | 1,640 ARS | 0.0% | 1,682 ARS | 1,686 ARS | -0.39 | - | 0 | Off |
| 26 Jun 2026 | 1,640 ARS | 0.0% | 1,685 ARS | 1,687 ARS | -0.50 | - | 0 | Off |
| 19 Jun 2026 | 1,640 ARS | 0.0% | 1,689 ARS | 1,688 ARS | -0.64 | - | 0 | Off |
| 12 Jun 2026 | 1,640 ARS | 0.0% | 1,692 ARS | 1,689 ARS | -0.78 | - | 0 | Off |
| 5 Jun 2026 | 1,640 ARS | 0.0% | 1,696 ARS | 1,691 ARS | -0.93 | - | 0 | Off |
| 29 May 2026 | 1,640 ARS | 0.0% | 1,699 ARS | 1,692 ARS | -1.06 | - | 0 | Off |
| 22 May 2026 | 1,640 ARS | 0.0% | 1,702 ARS | 1,693 ARS | -1.15 | - | 0 | Off |
| 15 May 2026 | 1,640 ARS | 0.0% | 1,706 ARS | 1,695 ARS | -1.17 | - | 0 | Off |
| 8 May 2026 | 1,640 ARS | 0.0% | 1,709 ARS | 1,696 ARS | -1.16 | - | 0 | Off |
| 1 May 2026 | 1,640 ARS | 0.0% | 1,709 ARS | 1,698 ARS | -1.15 | - | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.